LifeMD, Inc.

Contributing Author

Recent Articles by LifeMD, Inc.

5 hours	LifeMD Reports First Quarter 2026 Results LFMD GlobeNewswire
Apr-27	LifeMD to Report First Quarter 2026 Financial Results on May 6 LFMD GlobeNewswire
Apr-10	LifeMD Now Offering Eli Lilly and Company's Foundayo (orforglipron), a New GLP-1 Pill for Weight Management LFMD GlobeNewswire
Mar-31	LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program LFMD GlobeNewswire
Mar-24	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LFMD GlobeNewswire
Mar-16	LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team LFMD +10.55% GlobeNewswire
Mar-09	LifeMD Reports Fourth Quarter and Full Year 2025 Results LFMD +25.32% LFMD GlobeNewswire
Mar-03	LifeMD to Participate in Two Investor Conferences During March LFMD +7.22% LFMD GlobeNewswire
Feb-23	LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 LFMD -6.38% GlobeNewswire
Jan-06	LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. LFMD +7.93% GlobeNewswire
Jan-05	LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy Pill LFMD +12.03% GlobeNewswire
Dec-26	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LFMD -12.50% GlobeNewswire
Nov-24	LifeMD Recognized by the 2025 Deloitte Technology Fast 500 and by TIME's America's Growth Leaders of 2026 LFMD GlobeNewswire
Nov-17	LifeMD Reports Third Quarter 2025 Results LFMD -13.53% LFMD GlobeNewswire
Nov-17	LifeMD to Offer Market-Leading Pricing for GLP-1 Medications Wegovy and Ozempic in Continued Collaboration with Novo Nordisk LFMD GlobeNewswire
Nov-10	LifeMD to Participate in the BTIG Digital Health Forum LFMD GlobeNewswire
Nov-05	LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17 LFMD -6.57% LFMD GlobeNewswire
Nov-04	LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform LFMD -5.57% GlobeNewswire
Oct-23	LifeMD to Report Third Quarter 2025 Financial Results on November 6 LFMD GlobeNewswire
Oct-22	LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program LFMD GlobeNewswire
Sep-30	LifeMD Offers Ozempic at $499 Per Month through Collaboration with Novo Nordisk LFMD +5.43% GlobeNewswire
Sep-25	LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference LFMD GlobeNewswire
Sep-23	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LFMD GlobeNewswire
Sep-18	LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale LFMD +5.76% GlobeNewswire
Aug-28	LifeMD to Participate in Three Investor Conferences During September LFMD GlobeNewswire
Aug-05	LifeMD Reports Second Quarter 2025 Results LFMD -44.85% LFMD GlobeNewswire
Aug-04	LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference LFMD +24.25% GlobeNewswire
Jul-31	LifeMD Names COO and Promotes Two Executives LFMD GlobeNewswire
Jul-29	LifeMD to Report Second Quarter 2025 Financial Results on August 5 LFMD -6.16% GlobeNewswire
Jun-23	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LFMD GlobeNewswire
Jun-09	LifeMD to Participate in Two Investor Conferences During June LFMD GlobeNewswire
May-22	LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy LFMD +6.78% GlobeNewswire
May-12	LifeMD to Participate in Three Investor Conferences During May LFMD GlobeNewswire
May-06	LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance LFMD GlobeNewswire

LifeMD, Inc.

Recent Articles by LifeMD, Inc.

Upgrade your Finviz experience